fbpx
Instagram Twitter Linkedin-in Youtube
GET IN TOUCH

List – 44 Drug Patents that are Expiring in 2029

Life Sciences

Meet The Authors

The list includes not just the drug names but also other information like yearly sales, treatment, ingredients, and the disease they cure which could help them (you) easily choose the drug most profitable to develop a generic version.

Without any delay, here is the list of drugs. Thank us later!

The article has a list of drug patents expiring in 2029. You can get the drug patents expiration list from 2026 to 2030 in a PDF by filling out the form below.

Drug Patent Expiration Report

Download the Drug Expiration Report 2026-2030 in pdf:​

Drug Patent Expiration Report



Download PDF

Lamictal Odt

Lamotrigine

PatentsExpiration Date
US7919115January 4, 2029

Dosage: Oral
Company: GlaxoSmithKline
Ingredients: LAMOTRIGINE
Treatment: Epilepsy

Wakix

Pitolisant

PatentsExpiration Date
US8207197February 25, 2029

Dosage: Oral
Company: Harmony Biosciences Llc
Ingredients: PITOLISANT HYDROCHLORIDE
Treatment: Excessive Daytime Sleepiness

Caplyta

Lumateperone

PatentsExpiration Date
US9586960March 12, 2029
USRE48825March 12, 2029
US8648077December 1, 2029

Dosage: Oral
Company: Intra-cellular Therapies Inc
Ingredients: LUMATEPERONE TOSYLATE
Treatment: Schizophrenia And Bipolar Depression

Desyrel

Trazodone

PatentsExpiration Date
US8133893March 13, 2029

Dosage: Oral
Company: Pragma Pharmaceuticals Llc
Ingredients: TRAZODONE HYDROCHLORIDE
Treatment: Major Depressive Disorder, Anxiety Disorders, and Difficulties With Sleep

Neuraceq

Florbetaben

PatentsExpiration Date
US7807135March 18, 2029

Dosage: Intravenous
Company: Life Molecular Imaging Ltd
Ingredients: FLORBETABEN F-18
Treatment: Alzheimer’s Disease

Monoferric

Ferric derisomaltose

PatentsExpiration Date
US10414831March 25, 2029
US8815301August 14, 2029

Dosage: Intravenous
Company: Pharmacosmos As
Ingredients: FERRIC DERISOMALTOSE
Treatment: Iron Deficiency Anemia

Gemtesa

Vibegron

PatentsExpiration Date
US8653260April 2, 2029
US8247415December 1, 2030

Dosage: Oral
Company: Urovant Sciences Gmbh
Ingredients: VIBEGRON
Treatment: Overactive Bladder

Kerendia

Finerenone

PatentsExpiration Date
US8436180April 12, 2029

Dosage: Oral
Company: Bayer Healthcare Pharmaceuticals Inc
Ingredients: FINERENONE
Treatment: Kidney Function

Triferic

Ferric Pyrophosphate Citrate

PatentsExpiration Date
US7816404April 17, 2029

Dosage: Intravenous
Company: Rockwell Medical Inc
Ingredients: FERRIC PYROPHOSPHATE CITRATE
Treatment: Iron Deficiency Anemia

Cipro

Ciprofloxacine

PatentsExpiration Date
US9603796April 21, 2029

Dosage: Oral, Intravenous, Topical
Company: Alk-abello Inc
Ingredients: CIPROFLOXACIN
Treatment: Bacterial Infections

Veklury

Remdesivir

PatentsExpiration Date
USRE46762April 22, 2029
US8318682April 22, 2029
US8008264September 6, 2029
US10065958September 16, 2031
US9724360October 29, 2035
US9949994October 29, 2035

Dosage: Intravenous
Company: Gilead Sciences Inc
Ingredients: REMDESIVIR
Treatment: Antiviral

Zejula

Niraparib

PatentsExpiration Date
US8436185April 24, 2029
US8071623March 27, 2031

Dosage: Oral
Company: GlaxoSmithKline Llc
Ingredients: NIRAPARIB TOSYLATE
Treatment: Anti-cancer

Zeposia

Ozanimod

PatentsExpiration Date
US8481573May 14, 2029
US8796318May 14, 2029

Dosage: Oral
Company: Celgene International Ii Sarl
Ingredients: OZANIMOD HYDROCHLORIDE
Treatment: Multiple Sclerosis And Ulcerative Colitis

Tauvid

Flortaucipir (18F)

PatentsExpiration Date
US8932557May 19, 2029

Dosage: Intravenous
Company: Avid Radiopharmaceuticals Inc
Ingredients: FLORTAUCIPIR F-18
Treatment: Radioactive Diagnostic Agent

Opana Er

Oxymorphone

PatentsExpiration Date
US7851482July 10, 2029
US8871779November 22, 2029

Dosage: Oral
Company: Endo Pharmaceuticals Inc
Ingredients: OXYMORPHONE HYDROCHLORIDE
Treatment: Severe Pain

Braftovi

Encorafenib

PatentsExpiration Date
US8946250July 23, 2029
US8541575February 26, 2030
US9593099August 27, 2030
US8501758March 4, 2031

Dosage: Oral
Company: Array Biopharma Inc
Ingredients: ENCORAFENIB
Treatment: Melanoma

Odomzo

Sonidegib

PatentsExpiration Date
US8178563July 24, 2029
US8063043September 15, 2029

Dosage: Oral
Company: Sun Pharmaceutical Industries Ltd
Ingredients: SONIDEGIB PHOSPHATE
Treatment: Cancer

Zepatier

Elbasvir/Grazoprevir

PatentsExpiration Date
US7973040July 24, 2029
US8871759May 4, 2031

Dosage: Oral
Company: Merck Sharp And Dohme Corp
Ingredients: ELBASVIR; GRAZOPREVIR
Treatment: Hepatitis C

Talzenna

Talazoparib

PatentsExpiration Date
US8420650July 27, 2029
US8012976October 19, 2029
US10189837October 20, 2031
US8735392October 20, 2031

Dosage: Oral
Company: Pfizer Inc
Ingredients: TALAZOPARIB TOSYLATE
Treatment: Breast Cancer

Evotaz

Atazanavir/Cobicistat

PatentsExpiration Date
US8148374September 3, 2029

Dosage: Oral
Company: Bristol-Myers Squibb Co
Ingredients: ATAZANAVIR SULFATE; COBICISTAT
Treatment: HIV/AIDS

Piqray

Alpelisib

PatentsExpiration Date
US8476268September 10, 2029
US8227462September 28, 2030

Dosage: Oral
Company: Novartis Pharmaceuticals Corp
Ingredients: ALPELISIB
Treatment: Breast Cancer

Tykerb

Lapatinib

PatentsExpiration Date
US8821927September 18, 2029

Dosage: Oral
Company: Novartis Pharmaceuticals Corp
Ingredients: LAPATINIB DITOSYLATE
Treatment: Breast Cancer

Treanda

Bendamustine

PatentsExpiration Date
US8445524September 26, 2029

Dosage: Intravenous
Company: Cephalon Inc
Ingredients: BENDAMUSTINE HYDROCHLORIDE
Treatment: Chronic Lymphocytic Leukemia, Multiple Myeloma, And Non-Hodgkin’s Lymphoma

Ingrezza

Valbenazine

PatentsExpiration Date
US8039627October 6, 2029
US10065952October 28, 2036
US10844058October 28, 2036
US10851103October 28, 2036
US10851104October 28, 2036
US10906902December 22, 2036
US10919892December 22, 2036
US10906903December 22, 2036

Dosage: Intravenous
Company: Neurocrine Biosciences Inc
Ingredients: VALBENAZINE TOSYLATE
Treatment: Tardive Dyskinesia

Vitrakvi

Larotrectinib

PatentsExpiration Date
US9127013October 21, 2029
US8513263December 23, 2029
US10172861November 16, 2035
US10799505August 15, 2036

Dosage: Oral
Company: Bayer Healthcare Pharmaceuticals Inc
Ingredients: LAROTRECTINIB SULFATE
Treatment: Cancer

Rezurock

Belumosudil

PatentsExpiration Date
US8357693October 30, 2029

Dosage: Oral
Company: Kadmon Pharmaceuticals Llc
Ingredients: BELUMOSUDIL MESYLATE
Treatment: Chronic Graft Versus Host Disease

Cotellic

Cobimetinib

PatentsExpiration Date
US7803839November 10, 2029
US10478400June 29, 2036
US10590102June 30, 2036

Dosage: Oral
Company: Genentech Inc
Ingredients: COBIMETINIB FUMARATE
Treatment: Anti-cancer

Recarbrio

Imipenem/Cilastatin/Relebactam

PatentsExpiration Date
US8487093November 19, 2029

Dosage: Intravenous
Company: Merck Sharp And Dohme 
Ingredients: CILASTATIN SODIUM; IMIPENEM; RELEBACTAM
Treatment: Urinary Tract And Complicated Intra-abdominal Infections

Belsomra

Suvorexant

PatentsExpiration Date
US7951797November 20, 2029

Dosage: Oral
Company: Merck Sharp And Dohme 
Ingredients: SUVOREXANT
Treatment: Insomnia

Verzenio

Abemaciclib

PatentsExpiration Date
US7855211December 15, 2029

Dosage: Oral
Company: Eli Lilly And Co
Ingredients: ABEMACICLIB
Treatment: Breast Cancers

Tavneos

Avacopan

PatentsExpiration Date
US8906938December 21, 2029
US8445515February 3, 2031

Dosage: Oral
Company: Chemocentryx Inc
Ingredients: AVACOPAN
Treatment: Anti-neutrophil Cytoplasmic Auto antibody-associated Vasculitis

Ibsrela

Tenapanor

PatentsExpiration Date
US8541448December 30, 2029
US8969377December 30, 2029

Dosage: Oral
Company: Ardelyx Inc
Ingredients: TENAPANOR HYDROCHLORIDE
Treatment: Irritable Bowel Syndrome

Eucrisa

Crisaborole

PatentsExpiration Date
US8039451December 29, 2029

Dosage: Topical
Company: Anacor Pharmaceuticals Inc
Ingredients: CRISABOROLE
Treatment: Atopic Dermatitis

Share This Article:

Table of Contents

Related Articles

[crp]

More Curated Insights For You

5 Types of Patent Examiners

Smart Patent Prosecution – 5 Types of Patent Examiners You Should Know!

Innovation often starts with a “light bulb moment”. One works on their idea and then from idea, s/he moves to invention, and in the end to a patent application. Thereafter

READ MORE
Not targeting small companies for patent licensing? Think Again

You may lose loads of money by not targeting small players for patent licensing

I faced a similar situation recently. Had I struck off this small company on my list, our client could have potentially lost millions of dollars.  So today, I am here

READ MORE
KJ Method can help your R&D team innovate faster

KJ Method can help your R&D team innovate faster, Here’s how

READ MORE
5 Strategic patent acquisitions you should know about

5 strategic patent acquisitions you should know about

“The decision of acquiring patents is some work! Starting from getting hold of a certain bunch of patents to making strategies looking at the various aspects that could affect the

READ MORE

What is the Problem with current outsourced report CXOs consume?

“The CTO’s key tasks are not those of lab director writ large but, rather, of a technical business person deeply involved in shaping and implementing overall corporate strategy.” ~~ W.W.

READ MORE
A New Non-Invasive Solution Changing Eye Treatment Forever!

No needles, no drops: Biophta tackles blindness risks with a 7-Day gel tablet

Approximately 1 billion patients have lost sight due to ocular diseases, even though multiple treatments exist. Half of the patients find it hard to keep up with their eye treatments,

READ MORE

Facing A Roadblock On Your Project?

Our Experts Are Here To Help.

Project Queries

Deepak Syal (Director)

+91-8297806050
Chakshu Kalra (Director)
+91-9878481471
United States
+1-202-455-5058
Singapore
+65 84306322